Skip to main content
SpringerLink
Log in

NICE guidance on tamoxifen prescribing has slow uptake

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. National Institute for Health and Care Excellence

  2. National Health Service

Reference

  • Curtis HJ, et al. Impact of NICE guidance on tamoxifen prescribing in England 2011-2017: an interrupted time series analysis. British Journal of Cancer : 23 Apr 2018. Available from: URL: http://doi.org/10.1038/s41416-018-0065-2

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

NICE guidance on tamoxifen prescribing has slow uptake. PharmacoEcon Outcomes News 802, 21 (2018). https://doi.org/10.1007/s40274-018-4912-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4912-4

Search

Navigation